Premium
Intravenous OxyContin‐associated thrombotic microangiopathy treated successfully without plasma exchange
Author(s) -
Tate Courtney,
Mollee Peter
Publication year - 2015
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja14.01125
Subject(s) - thrombotic microangiopathy , medicine , therapeutic plasma exchange , microangiopathy , endocrinology , diabetes mellitus , disease
A 56-year-old man of European ancestry with no clinically significant medical history presented with a 3-day history of periumbilical abdominal pain. He admitted to daily intravenous (IV) misuse of oral extended-release oxycodone hydrochloride (OxyContin; Mundipharma) over a period of months. For the 5 weeks before presentation, he had been injecting the new tamper-resistant formulation because he was unable to access the discontinued crushable form.